Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-03

Clinical Trial Update: Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating estetrol for female sexual arousal disorder in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estetrol (estetrol)

Snippet

Sponsor: Estetra | Conditions: Sexual Dysfunction, Physiological | Phase 2 | Status: COMPLETED